Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00909454 · ClinicalTrials.gov registry record · NA

Vitamin D Supplement Study for Adolescents

A NA study, sponsored by Augusta University.

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT00909454: Completed NA study, sponsored by Augusta University.

NCT00909454 is a NA study that has completed, run by Augusta University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00909454, a NA study, has completed, sponsored by Augusta University.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

The purpose of this study is to determine if 14-19 year old African American adolescents are able to take a daily vitamin D supplement daily for about 4 months and how well a daily dose of 400 IU or 2000 IU vitamin D supplement raises their vitamin D blood level.

Interventions

  • DIETARY_SUPPLEMENT 2000 IU Vitamin D3 daily supplement
  • DIETARY_SUPPLEMENT 400 IU Vitamin D3 supplement

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2009-02
Est. Completion 2009-06
Phase NA
Augusta University

106 total trials

What the finished NCT00909454 record still lists

NCT00909454 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which 2000 IU Vitamin D3 daily supplement is the first listed.

NCT00909454 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00909454 about?

NCT00909454 is a clinical study titled "Vitamin D Supplement Study for Adolescents". The purpose of this study is to determine if 14-19 year old African American adolescents are able to take a daily vitamin D supplement daily for about 4 months and how well a daily dose of 400 IU or 2000 IU vitamin D supplement raises their vitamin D blood level.

What is the current status of trial NCT00909454?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2009-02. Estimated completion is 2009-06.

What interventions are being tested in trial NCT00909454?

The interventions under investigation include: 2000 IU Vitamin D3 daily supplement (DIETARY_SUPPLEMENT), 400 IU Vitamin D3 supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00909454?

This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00909454's enrollment target sits among peer trials

45 1411th of 2000 higher than 578 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00909454, the US trial registry maintained by the National Library of Medicine. NCT00909454 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.